Anika Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Anika Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$29.9M, a 355% decline year-over-year.
  • Anika Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$97.5M, a 297% decline year-over-year.
  • Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$82.7M, a 456% decline from 2022.
  • Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 459% decline from 2021.
  • Anika Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $4.13M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$97.5M -$29.9M -$23.3M -355% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$74.2M -$88K +$2.65M +96.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-04
Q1 2024 -$76.8M -$4.51M +$5.84M +56.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-04
Q4 2023 -$82.7M -$63M -$58.1M -1184% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$24.6M -$6.58M -$2.4M -57.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$22.2M -$2.74M +$102K +3.59% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-04
Q1 2023 -$22.3M -$10.4M -$7.42M -253% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-04
Q4 2022 -$14.9M -$4.91M +$885K +15.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$15.7M -$4.18M -$4.73M -848% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$11M -$2.84M -$9.37M -144% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$1.64M -$2.93M -$5.77M -203% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 $4.13M -$5.79M +$9.86M +63% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$5.73M $558K +$6.97M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$12.7M $6.53M +$14.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$26.9M $2.84M -$2.96M -51% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$24M -$15.7M -$19.7M -486% Oct 1, 2020 Dec 31, 2020 10-K/A 2021-04-26
Q3 2020 -$4.28M -$6.41M -$15.6M -170% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $11.3M -$7.71M -$17.1M -182% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 $28.5M $5.79M +$1.29M +28.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 $27.2M $4.05M -$3.67M -47.5% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $30.9M $9.2M +$1.6M +21.1% Jul 1, 2019 Sep 30, 2019 10-K/A 2021-04-26
Q2 2019 $29.3M $9.44M -$657K -6.51% Apr 1, 2019 Jun 30, 2019 10-K/A 2021-04-26
Q1 2019 $29.9M $4.51M +$11.2M Jan 1, 2019 Mar 31, 2019 10-K/A 2021-04-26
Q4 2018 $18.7M $7.72M -$350K -4.34% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-06
Q3 2018 $19.1M $7.6M +$712K +10.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-06
Q2 2018 $18.4M $10.1M -$1.28M -11.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-06
Q1 2018 $19.6M -$6.69M -$12.2M -222% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-06
Q4 2017 $31.8M $8.07M -$18K -0.22% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $31.8M $6.89M -$2.07M -23.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 $33.9M $11.4M +$2.75M +32% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 $31.1M $5.49M -$1.4M -20.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 $32.5M $8.09M -$2.96M -26.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $35.5M $8.95M +$572K +6.83% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 $34.9M $8.62M +$795K +10.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 $34.1M $6.9M +$3.38M +96.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 $30.8M $11M +$3.23M +41.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-24
Q3 2015 $27.5M $8.38M +$2.21M +35.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-24
Q2 2015 $25.3M $7.82M -$1.48M -15.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-24
Q1 2015 $26.8M $3.52M -$11.5M -76.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-24
Q4 2014 $38.3M $7.82M +$1.16M +17.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 $37.2M $6.17M +$1.21M +24.5% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 $35.9M $9.3M +$3.41M +57.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 $32.5M $15M +$12M +390% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 $20.6M $6.65M +$2.19M +49.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 $18.4M $4.96M +$3.31M +201% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 $15.1M $5.89M +$2.16M +57.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 $12.9M $3.07M +$1.16M +60.5% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
Q4 2012 $11.8M $4.46M +$1.58M +54.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 $10.2M $1.65M -$1.33M -44.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-13
Q2 2012 $11.5M $3.74M +$1.45M +63.7% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 $10.1M $1.91M +$1.59M +489% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
Q4 2011 $8.47M $2.88M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 $2.98M +$1.79M +151% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 $2.28M +$1.22M +114% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 $324K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
Q3 2010 $1.18M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.07M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.